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 Purpose: To evaluate in vivo sentinel lymph node (SLN) mapping 
by using photoacoustic and ultrasonographic (US) imaging 
with a modifi ed clinical US imaging system.
 Materials and 
Methods: 
Animal protocols were approved by the Animal Studies 
Committee. Methylene blue dye accumulation in axillary 
lymph nodes of seven healthy Sprague-Dawley rats was 
imaged by using a photoacoustic imaging system adapted 
from a clinical US imaging system. To investigate clinical 
translation, the imaging depth was extended up to 2.5 cm 
by adding chicken or turkey breast on top of the rat skin 
surface. Three-dimensional photoacoustic images were 
acquired by mechanically scanning the US transducer and 
light delivery fi ber bundle along the elevational direction.
 Results: Photoacoustic images of rat SLNs clearly help visualization 
of methylene blue accumulation, whereas coregistered 
photoacoustic/US images depict lymph node positions rela-
tive to surrounding anatomy. Twenty minutes following 
methylene blue injection, photoacoustic signals from SLN 
regions increased nearly 33-fold from baseline signals in 
preinjection images, and mean contrast between SLNs and 
background tissue was 76.0  6 23.7 (standard deviation). 
Methylene blue accumulation in SLNs was confi rmed pho-
toacoustically by using the optical absorption spectrum of 
the dye. Three-dimensional photoacoustic images demon-
strate dynamic accumulation of methylene blue in SLNs 
after traveling through lymph vessels.
 Conclusion: In vivo photoacoustic and US mapping of SLNs was 
successfully demonstrated with a modifi ed clinical US 
scanner. These results raise confi dence that photoacoustic 
and US imaging can be used clinically for accurate, nonin-
vasive imaging of SLNs for axillary lymph node staging in 
breast cancer patients.
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tumors, and internal organs) ( 24,25 ) 
and function (eg, tumor hypoxia and 
dynamic brain activities) ( 18,19,26,27 ). 
Moreover, exogenous contrast agents, 
such as organic dyes, nanoparticles, 
reporter genes, and fl uorescent proteins, 
have enabled photoacoustic molecular 
imaging ( 26,28–31 ). A tabletop photoa-
coustic imaging system that is based on 
mechanical raster scanning has been 
applied to identify rat SLNs in vivo by 
using methylene blue dye, gold nano-
particles, and single-walled carbon nano-
tubes ( 32–35 ). However, the imaging 
speed of this system (approximately 8 
minutes for a 24  3 24-mm 2 fi eld of view) 
limits its clinical applicability owing to 
mechanical scanning. 
 Our purpose was to evaluate in vivo 
SLN mapping by using photoacoustic 
and US imaging with a modifi ed clinical 
US imaging system. 
 Materials and Methods 
 Three authors (T.N.E., L.J., M.D.P.) 
are employees of Philips Research North 
America (Briarcliff Manor, NY). Authors 
cancer patients. The combination of 
ultrasonography (US)-guided fi ne-needle 
aspiration biopsy (FNAB) and molecu-
lar analysis by using real-time reverse 
transcription–polymerase chain reac-
tion is emerging as a viable, minimally 
invasive alternative to SLNB ( 10–13 ). 
Although axillary US imaging can pro-
vide morphologic information, such as 
size and shape of lymph nodes, it can-
not be used to specifi cally identify SLNs, 
reducing the sensitivity of US-guided 
FNAB ( 14 ). Noninvasive fl uorescence 
imaging has been used to identify SLNs 
by using indocyanine green dye ( 15–17 ). 
Despite the use of nonionizing radia-
tion, this technique requires surgical 
isolation of lymph nodes because of its 
poor depth penetration. 
 Photoacoustic imaging is a nonion-
izing and noninvasive hybrid imaging 
technique that can supply strong optical 
absorption contrasts with high US spatial 
resolution ( 18,19 ). Photoacoustic imag-
ing relies on the photoacoustic effect for 
generating pressure waves under ther-
mal and stress confi nement conditions. 
A short pulsed laser is used to irradiate 
tissue, causing optical absorption, rapid 
thermoelastic expansion, and acoustic 
pressure wave generation. For photoa-
coustic imaging in the diffusive regimen, 
spatial resolution is determined by the 
acoustic detector, and both image reso-
lution and depth are highly scalable with 
the US frequency. Since US scattering 
is two to three orders of magnitude 
less than optical scattering on the basis 
of per-unit path length, photoacoustic 
imaging can break through the funda-
mental limitation of existing pure optical 
imaging ( 20–23 ). With the use of intrin-
sic contrast agents such as hemoglobin 
or melanin, photoacoustic tomography 
can be used to image both morphology 
(eg, vascular structures, angiogenesis, 
 Sentinel lymph node (SLN) biopsy (SLNB) has emerged as the pre-ferred method for axillary lymph 
node staging of breast cancer patients 
with clinically negative axillary lymph 
nodes ( 1–3 ). The fi rst lymph nodes 
receiving drainage from the tumor are 
defi ned as SLNs and are most likely to 
be positive for metastases. The general 
process of SLNB includes the following: 
 (a) identifi cation of SLNs by using ra-
dioactive colloids (eg, technetium 99m 
sulfur colloid) and invasive visual confi r-
mation of SLNs by using blue dyes (eg, 
isosulfan blue or methylene blue),  (b) 
surgical resection of SLNs, and  (c) his-
tologic assessment of excised SLNs. If 
pathologic results for SLNs are negative, 
then full axillary lymph node dissection 
can be avoided. High identifi cation rates 
(90%–97%) and low false-negative rates 
(5%–10%) can be achieved with SLNB 
following injection of radioactive tracers 
and blue dye ( 4–6 ). 
 Although SLNB aids in the reduction 
of morbidity and side effects, as compared 
with axillary lymph node dissection, it 
still remains an invasive surgical proce-
dure with potential postoperative com-
plications, which include lymphedema, 
seroma formation, sensory nerve injury, 
and range-of-motion limitations ( 7,8 ). In 
a clinical trial, researchers found that, in 
74.2% (3989 of 5379) of breast cancer 
patients who underwent SLN resection, 
fi ndings were pathologically negative ( 9 ). 
For most of the patients who undergo 
SLNB, a noninvasive or minimally inva-
sive alternative could be used effectively 
for staging the axillary lymph nodes with-
out requiring surgical intervention. Fur-
thermore, with conventional SLNB, ion-
izing radiation is used to identify SLNs, 
so a solution without ionizing radiation 
would be advantageous. 
 The capability to noninvasively iden-
tify SLNs would allow targeted needle 
biopsies for defi nitive diagnosis in breast  Implication for Patient Care 
 The dual-modality photoacoustic  n
and US imaging system can 
potentially be used clinically to 
guide fi ne-needle aspiration biop-
sies of SLNs for axillary lymph 
node staging in breast cancer 
patients. 
 Advance in Knowledge 
 Noninvasive photoacoustic and  n
US imaging can help in mapping 
rat sentinel lymph nodes (SLNs) 
and lymph vessels by using meth-
ylene blue dye in vivo. 




 FNAB = fi ne-needle aspiration biopsy 
 MAP= maximum amplitude projection 
 SLN = sentinel lymph node 
 SLNB = SLN biopsy 
 3D = three-dimensional 
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B; Quantel, Les Ulis, France) with a 6.5-
nanosecond pulse duration and a 10-Hz 
pulse repetition rate, was  delivered 
through a high-temperature epoxy, mul-
timode fi ber bundle (Schott Fiber Optics, 
Southbridge, Mass). The optical wave-
length was tunable between 606 and 
678 nm, which covered the peak optical 
absorption wavelength of methylene blue 
(667 nm). Unless otherwise noted, pho-
toacoustic images were acquired by using 
658-nm light. On the basis of the laser 
power spectrum, this wavelength pro-
duced the strongest photoacoustic signals 
from methylene blue. The light fl uence 
on the skin was less than 5 mJ/cm 2 , 
well within American National Standards 
Institute safety limits ( 38 ). 
 The fi ber bundle was physically 
attached to a US probe to enable dual-
modality photoacoustic and US imag-
ing. The fi nal optical illumination pat-
tern on the skin surface was rectangle 
shaped (3  3 1 cm along the x-axis and 
y-axis, respectively). The imaging plane 
of the US probe was coaxially aligned 
with the oblique incidence (approxi-
mately 45°) of the rectangle-shaped 
optical beam on the targeted area. 
The photoacoustic probe was partially 
immersed in a water tank, which had 
an opening at the bottom sealed with a 
thin, disposable, clear membrane. Rats 
system for image display and postpro-
cessing, providing dual-modality imaging 
capability. Photoacoustic images were 
reconstructed by using a Fourier beam-
forming algorithm ( 37 ) implemented in 
software (Matlab; MathWorks, Natick, 
Mass), generating a photoacoustic 
B-mode image from one laser shot. 
A fi eld-programmable gate array–based 
electronic board synchronized data 
acquisition with the laser fi ring. Photoa-
coustic data capture at a frame rate of 
10 frames per second was limited by the 
current laser repetition rate (described 
next) but ultimately can be enhanced 
to 50 frames per second with a suitable 
laser source. Beam-formed photoacous-
tic images can be displayed at a frame 
rate of approximately 1 frame per sec-
ond, limited by image reconstruction. 
 The system can use all standard iU22 
array transducers for both photoacous-
tic and US imaging. For this study, three 
focused US array transducers were used: 
the phased-array S5-1 probe (80 ele-
ments, 1–5 MHz) and two linear-array 
probes, L8-4 (128 elements, 4–8 MHz) 
and L15-7io (128 elements, 7–15 MHz). 
 Photoacoustic Imaging System 
 Light from a tunable dye laser (ND6000; 
Continuum, Santa Clara, Calif), pumped 
by a Q-switched Nd:YAG laser (Brilliant 
who are not employees of industry (C.K., 
L.V.W.) maintained control of the data 
that could have been a confl ict for the 
industry authors. One author (L.V.W.) 
has a fi nancial interest in Microphotoa-
coustics (Ronkonkoma, NY) and Endra 
(Ann Arbor, Mich), which, however, did 
not support this work. 
 Animal and Dye Preparation 
 Animal protocols were approved by the 
Animal Studies Committee, and animal 
handling was performed according to 
the Guide for the Care and Use of Labo-
ratory Animals. Animal experiments 
were conducted between March 12, 
2009, and May 26, 2009. Seven healthy 
Sprague-Dawley rats (Harlan Labora-
tories, Indianapolis, Ind; weight range, 
250–390 g) were initially anesthetized 
by using a mixture of ketamine (Ketaset, 
Fort Dodge Animal Health, Fort Dodge, 
Iowa) at a dose of 85 mg/kg and xylazine 
(AnaSed; Akorn, Decatur, Ill) at a dose 
of 15 mg/kg. The hair in the left axillary 
region was gently depilated before imag-
ing. Photoacoustic and US images were 
collected before and after a 0.1-mL intra-
dermal injection of a 1% (10 mg/mL) 
solution of methylene blue dye (Ameri-
can Regent, Shirley, NY), at 10 mg/mL, 
in the left forepaw pad. In the animals, 
full anesthesia was maintained through-
out the experiment by using isofl urane 
gas, administered with 1 L/min of oxy-
gen and 0.75% of isofl urane (Euthanex, 
Palmer, Pa). Simultaneously, both heart 
rate and saturation of peripheral oxygen 
were monitored by using a pulse oxime-
ter (8600V; Nonin Medical, Plymouth, 
Minn). After imaging, animals were euth-
anized with an overdose of pentobarbital 
(Sleepaway; Fort Dodge Animal Health), 
and SLNs were dissected. 
 US Imaging System 
 A photoacoustic imaging system ( Fig 1 ) 
was built around a clinical US imaging sys-
tem (iU22; Philips Healthcare, Andover, 
Mass) ( 36 ). The modifi ed channel-board 
architecture allowed access to raw per-
channel photoacoustic data, while all 
imaging capabilities of an actual com-
mercial US scanner were retained. Raw 
photoacoustic and US data were trans-
ferred to a custom-built data acquisition 
 Figure 1 
  
 Figure 1: Experimental setup of photoacoustic imaging system adapted from a modifi ed US 
imaging system.  x  = X-axis,  y = y-axis , z = z-axis.  
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from SLN regions before and after meth-
ylene blue injection.  P values were 
computed from a one-tailed distribu-
tion and were considered to indicate a 
signifi cant difference if they were less 
than .05. Photoacoustic signal enhance-
ment was defi ned as the ratio between 
post- and preinjection signal amplitudes 
from SLN regions. Photoacoustic con-
trast was defi ned as the ratio between 
signal amplitudes from SLNs and tissue 
background. Correlation coefficients 
were computed between measured 
photoacoustic spectra from SLNs and 
the optical absorption spectrum of 
methylene blue. All statistical analysis 
was performed by using software (Mat-
lab; MathWorks) with statistical tools 
(Statistics Toolbox; MathWorks). 
 Results 
 Preinjection photoacoustic B-mode 
images feature photoacoustic signals 
from superfi cial blood vessels and skin 
surfaces. Soon after injection, meth-
ylene blue accumulates in SLNs, as 
detected photoacoustically ( Fig 2 ). Pre- 
and postinjection images for each probe 
displayed with the same dynamic range 
demonstrate strong photoacoustic sig-
nal from SLNs following accumulation 
of methylene blue. Coregistered pho-
toacoustic and US images demonstrate 
the capability to combine functional 
(photoacoustic) and structural (US) fea-
tures for SLN mapping. 
 A sample postmortem photograph 
of the rat axillary region imaged during 
experiments is shown in  Figure 3 . The 
methylene blue–dyed SLN was visually 
identifi ed in the left axilla. Lymph nodes 
were typically 3  3 2 mm in size. 
 When imaging depth was increased 
by adding biologic tissue (either tur-
key or chicken breast tissue) on top of 
the rat skin surface, lymph nodes were 
imaged 2.4 cm and 2.5 cm below the top 
surface of the overlying tissue with the 
S5-1 ( Fig 4 ) and L8-4 probes, respec-
tively. Optical spectra that were based 
on photoacoustic signals from SLNs 
closely matched the optical absorption 
spectrum of methylene blue, confi rm-
ing the presence of methylene blue in 
detected lymph nodes ( R = 0.995). 
imaged by using the L8-4 probe. The 
 photoacoustic probe was scanned by 
a motion controller (ILS200PP; New-
port, Irvine, Calif) and translation stage 
(ESP300; Newport) in steps of 0.5 mm 
over a scanning distance of 2.5 cm, for a 
total fi eld of view of 2.3  3 2.5  3 5 cm. 
The total acquisition time for a 3D 
acquisition was 10 minutes. Photoa-
coustic maximum amplitude projection 
(MAP) images were reconstructed by 
fi rst removing the skin signal and then 
projecting the remaining maximum sig-
nal amplitude along each A-line onto 
the corresponding x - y plane. Volumetric 
photoacoustic images also were recon-
structed by using software (VolView; 
Kitware, Clifton Park, NY). 
 Image Display 
 Coregistered images displayed photoa-
coustic signals by using a pseudo-color 
map ranging from blue to red over gray-
scale B-mode US images. Photoacoustic 
signals below a threshold value were 
suppressed in coregistered images to 
aid interpretation. The threshold value 
was 9% of the peak photoacoustic signal 
from the SLN for images acquired with-
out additional overlying biologic tissue, 
whereas a threshold value of 30% was 
chosen for images with overlying tissue. 
Suitable threshold values were chosen on 
the basis of the signal-to-noise ratio of 
the photoacoustic signal from the SLN, 
which decreases at increasing depths. 
 Photoacoustic MAP images in the 
x-y plane were displayed before and 
after methylene blue injection. All MAP 
images were displayed by using the same 
dynamic range, color map, and magnifi -
cation. A composite color map consisting 
of gray-scale and blue portions was cho-
sen to easily visualize the blood vessels, 
the lymph vessels, and the lymph node 
in the same image. The blue color map 
displayed signal amplitudes greater than 
the maximum signal amplitude observed 
in the preinjection image to appreciate 
areas of enhanced signal amplitudes fol-
lowing methylene blue injection. 
 Statistical Analysis 
 Photoacoustic images were analyzed by 
using the nonparametric Wilcoxon signed 
rank test to compare signal amplitudes 
were placed below the water tank, in 
contact with the membrane by means 
of US coupling gel. 
 Experimental Procedures 
 Photoacoustic and US images were col-
lected before and after methylene blue 
injection in seven healthy Sprague-Dawley 
rats. Photoacoustic monitoring of the 
SLN following methylene blue injection 
continued for a mean of 77 minutes  6 
30 (standard deviation), with a range 
of 33–113 minutes. Of the seven rats, 
three were imaged with the L15-7io 
probe, two were imaged with the S5-1 
probe, and two were imaged with the 
L8-4 probe. 
 Spectroscopic photoacoustic imaging 
can be used to determine the presence 
of methylene blue dye without the need 
for a preinjection baseline image. Spec-
troscopic photoacoustic imaging ( n = 7) 
was performed by using eight optical 
wavelengths between 607 and 678 nm 
to confi rm that measured photoacous-
tic spectra of SLNs matched the optical 
absorption spectrum of methylene blue 
( 39 ). Thirty photoacoustic images were 
collected at each optical wavelength 
to determine the effect of shot-to-shot 
variations in laser pulse energy. 
 To investigate clinical translation at 
deeper imaging depths in humans, 2 cm 
of biologic tissue (chicken or turkey 
breast) was added on top of the skin of 
two rats, one imaged with the S5-1 probe 
and one imaged with the L8-4 probe. 
Pre- and postinjection photoacoustic and 
US images were acquired with the added 
tissue in place. For spectroscopic pho-
toacoustic imaging, the unknown opti-
cal attenuation spectrum of additional 
biologic tissue can affect the fl uence at 
the lymph node. Measured photoacous-
tic spectra from SLNs were normalized 
by the photoacoustic spectrum point by 
point from a small tube fi lled with meth-
ylene blue placed between the rat skin 
and the overlying tissue. 
 Three-dimensional (3D) photoa-
coustic images of SLNs and lymph 
vessels in three rats were acquired by 
mechanically scanning the photoacous-
tic probe along the elevational direc-
tion (y-axis). Two rats were imaged by 
using the L15-7io probe, and one was 
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increases by 30.6%, whereas the mean 
signal amplitude from the lymph vessel 
decreases by 48.6%. Signal amplitudes 
from blood vessels remained largely 
unchanged after injection. 
 Photoacoustic signal amplitudes from 
SLNs increase signifi cantly following 
toacoustic signals from the lymph vessel 
and SLN increase six and 17 times from 
preinjection baseline amplitudes, respec-
tively. As methylene blue travels from 
the lymph vessel to the SLN between 6 
and 31 minutes after injection, the mean 
signal amplitude from the lymph node 
 Three-dimensional photoacoustic 
images illustrate the propagation of meth-
ylene blue from lymph vessels to SLNs 
( Fig 5 ). Baseline MAP images acquired 
prior to methylene blue injection show 
the network of blood vessels in rat axillae. 
Soon after methylene blue injection, pho-
 Figure 2 
  
 Figure 2: Noninvasive photoacoustic B-mode images of SLNs show results from each probe from a different rat acquired in vivo with  (a–c) S5-1 probe,  (d–f) L8-4 
probe, and  (g–i) L15-7io probe.  (a, d, g) Control photoacoustic images acquired before methylene blue injection.  (b, e, h) Photoacoustic images acquired 20 minutes 
following methylene blue injection.  (c, f, i ) Coregistered photoacoustic and US images acquired 20 minutes following methylene blue injection.  X = x-axis,  Z = z-axis. 
Radiology: Volume 256: Number 1—July 2010 n radiology.rsna.org 107
 EXPERIMENTAL STUDIES: Photoacoustic and US Imaging of Rat Sentinel Lymph Nodes Erpelding et al
mJ/cm 2 ) ( 38 ). Because  photoacoustic 
signal strength depends on optical fl u-
ence and absorption, stronger opti-
cal fluence will enable photoacoustic 
SLN detection at even greater depths. 
Therefore, photoacoustic imaging should 
be capable of aiding in the noninva-
sive detection of axillary SLNs at most 
depths encountered in humans. Suc-
cessful noninvasive photoacoustic map-
ping of rat SLNs through 2.5 cm of tis-
sue motivates further evaluation of this 
technique and imaging devices in future 
trials in humans. 
 Our study had limitations. In cur-
rent experiments, photoacoustic and 
US images are acquired in a water tank 
with the optical fi ber bundle positioned 
close to the US probe, which is mounted 
on a mechanical translation stage. For 
clinical translation, freehand US is pre-
ferred. In the next phase of develop-
ment, light delivery will be integrated 
with the US probe to enable freehand 
scanning during photoacoustic and US 
image acquisition. In addition, 3D pho-
toacoustic images were acquired by 
mechanically scanning the photoacous-
tic probe, resulting in slow acquisition 
times (approximately 10 minutes for a 
2.3  3 2.5  3 5-cm fi eld of view). Faster 
3D images could be obtained by using 
positional tracking of the transducer 
position during freehand scanning to 
accommodate larger fi elds of view. 
Finally, turkey and chicken breast tis-
sue used to increase imaging depth may 
have lower blood content than human 
breast tissue. The penetration depth 
for photoacoustic imaging of SLNs 
will be more accurately assessed in 
human subjects during upcoming clinical 
experiments. 
 In summary, noninvasive photoa-
coustic and US mapping of rat SLNs and 
lymphatic vessels has been successfully 
demonstrated by using methylene blue 
dye with a modifi ed clinical US imaging 
system. 
 Practical application: The results 
from this study are an important step 
toward clinical translation of photoa-
coustic imaging for noninvasive SLN 
detection. Two key features of this 
technique are as follows:  (a) The mul-
timodality system for photoacoustic 
methylene blue injection ( P  , .008). 
In fi ve rats in which measurements 
were made without overlying biologic 
tissue, the mean photoacoustic signal 
enhancement of SLNs at 20 minutes 
after injection was 32.7  6 7.2 (range, 
25.3– 41.8) from preinjection baseline 
signals, and the mean contrast of SLNs 
relative to tissue background was 76.0  6 
23.7 (range, 46.1–112.2). In two rats in 
which measurements were made with 
overlaid biologic tissue, the photoa-
coustic signal enhancement values were 
5.4 (S5-1 probe) and 3.7 (L8-4 probe), 
and the contrast values were 8.3 (S5-1 
probe) and 4.6 (L8-4 probe). 
 Discussion 
 Noninvasive photoacoustic and US 
imaging have been used to map rat SLNs 
following methylene blue injection. This 
technique is highly translatable because 
it demonstrates photoacoustic detec-
tion of SLNs by using a modifi ed clini-
cal US imaging system, and methylene 
blue is used clinically in the United 
States during SLNB. Three US probes 
were used to successfully image uptake 
of methylene blue in SLNs and enable 
selection according to imaging require-
ments. As in conventional US, photoa-
coustic imaging depends on US probe 
frequency and bandwidth to determine 
spatial resolution, depth penetration, 
and sensitivity. 
 Rat axillary lymph nodes are super-
fi cial, in most cases only 1.5–3.0 mm 
below the skin surface. Human axillary 
lymph nodes are deeper but larger. 
Photoacoustic SLN mapping was dem-
onstrated at an imaging depth of 2.5 cm, 
without any signal averaging, by adding 
biologic tissue on top of the rat axillary 
skin. The investigators in a previous 
study ( 32 ) of photoacoustic SLN map-
ping in rats by using methylene blue 
reported a similar imaging depth of 2 cm 
without signal averaging and 3.1 cm 
with 50 times signal averaging. In the 
current study, optical fl uence on the 
skin was less than 5 mJ/cm 2 , which can 
be increased by a factor of four while 
still conforming to the  maximal permis-
sible exposure allowed by American 
National Standards Institute limits (20 
 Figure 3 
  
 Figure 3: Postmortem photograph of rat acquired 
after photoacoustic imaging and skin removal. Inset: 
Dissected SLN stained by using methylene blue. 
Skin was removed after rat was euthanized and 
imaging experiments were complete. 
 Figure 4 
  
 Figure 4: Coregistered photoacoustic and US 
B-mode images of rat SLNs acquired in vivo with 
added biologic tissue for increased imaging depth. 
 (a) SLN image acquired with S5-1 probe through 
additional 2-cm turkey breast 22 minutes follow-
ing methylene blue injection.  X = x-axis,  Z = z-axis. 
 (b) Graph shows confi rmation of methylene blue 
accumulation in SLNs by using spectroscopic photoa-
coustic imaging. Error bars = standard deviation from 
30 photoacoustic images collected at each optical 
wavelength,  MB Abs = methylene blue absorption, 
 PA  = photoacoustic. 
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 Figure 5 
  
 Figure 5: In vivo photoacoustic MAP images of rat axillary region.  (a) Control photoacoustic MAP image collected prior to methylene blue injection.  BV = blood 
vessel,  X = x-axis,  Y = y-axis.  (b, c, d) Photoacoustic MAP images collected 6, 20, and 31 minutes following methylene blue injection, respectively. Blue color map 
is used to display signal intensities above the maximum amplitude from the preinjection image. Color bar pertains to images  a – d .  LV  = lymph vessel. (e) Volumetric 
photoacoustic image of rat axilla 20 minutes following methylene blue injection.  Z = z-axis.  (f) Graph shows dynamic changes in photoacoustic signal amplitudes 
from SLN, lymph vessel, and blood vessel. Following methylene blue injection, signal intensities from SLN and lymph vessel increase strongly, and over time, the SLN 
signal continues to increase while lymph vessel signal decreases as methylene blue travels from the lymph vessel and accumulates in the lymph node. No substantial 
changes were observed in blood vessel signal amplitudes. Error bars = standard deviation from multiple pixels in each region of interest. 
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